Study shows association between breastfeeding and reduced risk of aggressive breast cancer
10/29/2015
New meta-analysis shows lower incidence of hormone receptor negative breast cancer in women who breastfed.
Landmark clinical trial shows gene-targeted drug can treat prostate cancer
10/28/2015
A pioneering drug developed to treat women with inherited cancers can also benefit men with advanced prostate cancer, a major new clinical trial concludes.
Landmark clinical trial shows gene-targeted drug can treat prostate cancer
10/28/2015
A pioneering drug developed to treat women with inherited cancers can also benefit men with advanced prostate cancer, a major new clinical trial concludes.
Retroviral RNA may play a part in liver cancer
10/28/2015
An international group led by RIKEN in Japan and INSERＭ in France have found that retroviral long-terminal-repeat (LTR) promoters - a type of repetitive element that are widely distributed in the...
FDA approves first-of-its-kind product for the treatment of melanoma
10/28/2015
The U.S. Food and Drug Administration has approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the skin and lymph...
Retroviral RNA may play a part in liver cancer
10/28/2015
An international group led by RIKEN in Japan and INSERＭ in France have found that retroviral long-terminal-repeat (LTR) promoters - a type of repetitive element that are widely distributed in the...
New treatment option for nonfunctional neuroendocrine tumours of the lung and gastrointestinal tract
10/28/2015
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or...
FDA approves first-of-its-kind product for the treatment of melanoma
10/28/2015
The U.S. Food and Drug Administration has approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the skin and lymph...
New treatment option for nonfunctional neuroendocrine tumours of the lung and gastrointestinal tract
10/28/2015
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or...
Radiotherapeutic bandage shows potential as treatment for skin cancer
10/28/2015
A radiotherapeutic bandage is being evaluated by researchers for efficacy against squamous cell carcinoma (SCC) in an animal model.